I’m curious whether the retinal blood barrier could act as a proxy measure for the blood brain barrier.
And thus the rapamycin impact on retinal health/function might act as a proxy for brain impact?
I ask because i personally have very detailed 6 monthly ophthalmology data due to a risk of early onset glaucoma. And so it will be interesting to see if my rapa protocol makes any measurable impact when I’m next tested.
Curious if anyone has any thoughts. On rapa and the retina
In this work, we have formulated a model compound, rapamycin(RAP), in nanoparticle-based eye drops and evaluated the delivery of RAP to the posterior eye tissues in a healthy rabbit.
The topical application of the MET-RAP eye drops to the EAU mouse model resulted in significant disease suppression compared to controls, with activity similar to dexamethasone eye drops. The MET-RAP eye drops also resulted in a reduction of RORγt and an increase in both Foxp3 expression and IL-10 secretion, indicating a mechanism involving the inhibition of Th17 cells and the up-regulation of T-reg cells. The MET-RAP formulation delivers RAP to the posterior eye segments, and the formulation is active in EAU.
The topical ocular delivery of rapamycin to posterior eye tissues and the suppression of retinal inflammatory disease
I’ll admit to experimentation with homemade rapa eyedrops. I can’t say it has had a noticeable effect, but it’s only been a few months. My motivation is to reduce the rate of development in a cataract. I’ve had no ill effects. I use 1 mg powdered rapa + 1 drop transcutol per 4 single-use containers/vials. Then I use 1 drop once or twice a day.
Yes insulin resistance is a risk factor for intra ocular pressure (iop)
My iop is well controlled but i have a familial risk and so monitor it regularly. But it will be interesting to see if rapa has any impact on both iop and function.